Publications in collaboration with researchers from Hospital Universitario Central de Asturias (11)

2016

  1. A single-institution analysis of the effect on local control of high-dose rate brachytherapy boost in a single 7 Gy fraction

    Revista de Senologia y Patologia Mamaria, Vol. 29, Núm. 2, pp. 63-68

2007

  1. Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse

    British Journal of Cancer, Vol. 97, Núm. 7, pp. 957-963

  2. Study of matrix metalloproteinases and their inhibitors in breast cancer

    British Journal of Cancer, Vol. 96, Núm. 6, pp. 903-911

2006

  1. Cytosolic levels of TFF1/pS2 in breast cancer: Their relationship with clinical-pathological parameters and their prognostic significance

    Breast Cancer Research and Treatment, Vol. 96, Núm. 1, pp. 63-72

2005

  1. Clinical significance of cathepsin D concentration in tumor cytosol of primary breast cancer

    International Journal of Biological Markers, Vol. 20, Núm. 2, pp. 103-111

  2. Clinical significance of the quantitative assessment of the cytosolic concentration of HER-2/neu protein in breast cancer by immunoenzymatic assay (ELISA)

    Journal of Cancer Research and Clinical Oncology, Vol. 131, Núm. 11, pp. 701-714

  3. Expression and prognostic value of EGFR in invasive breast cancer

    Oncology Reports, Vol. 14, Núm. 6, pp. 1655-1663

  4. Tissue-Type plasminogen activator (tPA) in breast cancer: Relationship with clinicopathological parameters and prognostic significance

    Breast Cancer Research and Treatment, Vol. 90, Núm. 1, pp. 33-40

2003

  1. Significación clínica del contenido tumoral del receptor del factor de crecimiento epidérmico en el cáncer de mama

    Revista Espanola de Medicina Nuclear, Vol. 22, Núm. 6, pp. 386-394

2002

  1. Analysis of the cytosolic content of the pS2 protein in breast cancer

    Revista Espanola de Medicina Nuclear, Vol. 21, Núm. 1, pp. 28-33

1997

  1. Clinical significance of preoperative serum levels of CA 125 and TAG-72 in ovarian carcinoma

    International Journal of Biological Markers, Vol. 12, Núm. 3, pp. 112-117